ERBB2 and breast carcinoma: There is no specific drug for TNBC, although hormone therapy is established for the treatment of ER+ breast cancer, and lapatinib, a small molecule inhibitor for human epidermal growth factor receptor 2, is employed for HER2 breast cancer, which also inhibits epidermal growth factor (EGF) receptor [10, 11].